Physician Assistant, Medical · Hagerstown, MD
NPI
1538310230
Since 2008
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
11236 Robinwood Dr Ste 204
Hagerstown, MD, 21742
Phone (888) 820-3376
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
2,106 services
Medicare patients, 2024
567
Average age 73
Drug cost, 2024
$1.5M
1,324 prescriptions
Company payments, 2025
$3,028
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cheri M Cartagena was code 17003 (destruction skin lesion), 504 times for 116 patients. In total Cheri M Cartagena billed 2,106 services in 61 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 504 | 116 | $3.62 | $1,826 |
| 99213 Office E&M - Established | Office | 448 | 354 | $43.64 | $20K |
| 17000 Destruction Skin Lesion | Office | 205 | 189 | $28.37 | $5,816 |
| 17110 Destruction Skin Lesion | Office | 159 | 142 | $59.31 | $9,430 |
| 99212 Office E&M - Established | Office | 135 | 117 | $25.99 | $3,509 |
| 99203 Office E&M - New | Office | 75 | 75 | $42.46 | $3,184 |
| 99214 Office E&M - Established | Office | 67 | 45 | $65.12 | $4,363 |
| 11102 Skin Biopsy | Office | 53 | 53 | $37.92 | $2,010 |
| 99202 Office E&M - New | Office | 42 | 42 | $29.68 | $1,247 |
| 11104 Skin Biopsy | Office | 36 | 36 | $64.17 | $2,310 |
| 11200 Removal or Shaving of Skin Growth | Office | 29 | 26 | $45.55 | $1,321 |
| 96372 Injection Administration | Office | 25 | 13 | $6.93 | $173 |
| 12032 Wound Repair - All Levels | Office | 14 | 14 | $175.78 | $2,461 |
By year: 2022 $189K for 4,358 services; 2023 $189K for 4,162 services; 2024 $72K for 2,106 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cheri M Cartagena prescribed most often to Medicare patients was Triamcinolone Acetonide, with 199 prescriptions and refills. In total Cheri M Cartagena wrote 1,324 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 199 | 231 | 129 | $2,238 |
| Ketoconazole Generic | 159 | 164 | 79 | $2,726 |
| Clobetasol Propionate Generic | 93 | 96 | 56 | $4,282 |
| Ammonium Lactate Generic | 79 | 84 | 51 | $2,128 |
| Metronidazole Generic | 59 | 63 | 35 | $3,017 |
| Opzelura Ruxolitinib Phosphate | 45 | 51 | 16 | $103K |
| Tretinoin Generic | 43 | 50 | 25 | $3,146 |
| Tacrolimus Generic | 36 | 48 | 23 | $7,835 |
| Hydroxyzine Hcl Generic | 35 | 43 | 11 | $242 |
| Clindamycin Phosphate Generic | 35 | 37 | 11 | $1,526 |
| Fluorouracil Generic | 32 | 32 | 22 | $1,734 |
| Otezla Apremilast | 31 | 31 | Under 11 | $155K |
| Minoxidil Generic | 29 | 57 | 13 | $223 |
| Mupirocin Generic | 24 | 24 | 14 | $168 |
| Dupixent Syringe Dupilumab | 23 | 25 | Under 11 | $95K |
Brand drugs: 321 claims; generic drugs: 1,003 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cheri M Cartagena $3,028 ($3,028 in general payments such as food, travel and fees) from 20 companies. The largest payer was Janssen Biotech, Inc. with $570.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 21 | $570 |
| Abbvie Inc. ABBV | 27 | $483 |
| Pfizer Inc. PFE | 17 | $353 |
| Novartis Pharmaceuticals Corporation NVS | 17 | $344 |
| UCB, Inc. UCB.BR | 7 | $200 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $180 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $170 |
| Galderma Laboratories, L.P. GALD.SW | 9 | $139 |
| Genzyme Corporation SNY | 1 | $125 |
| Incyte Corporation INCY | 5 | $97.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.